BPGAM
AZN icon

BTG Pactual Global Asset Management’s AstraZeneca AZN Stock Holding History

BTG Pactual Global Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-75,000
Closed -$6.07M – 65
2019
Q1 		$6.07M Buy
+75,000
New +$5.91M 2.32% 10

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BTG Pactual Global Asset Management's AZN Position: Q2 2019 in Review

BTG Pactual Global Asset Management sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 75,000 shares — an estimated $6.07M sold.

BTG Pactual Global Asset Management first reported a position in AZN in Q1 2019 and held it in 1 quarter. The position peaked at $6.07M in Q1 2019. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

  • BTG Pactual Global Asset Management reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 75,000 AstraZeneca shares in Q2 2019, an estimated $6.07M.
  • BTG Pactual Global Asset Management first reported a position in AstraZeneca in Q1 2019 and held it in 1 quarter.
  • BTG Pactual Global Asset Management's AstraZeneca position peaked at $6.07M in Q1 2019.
  • 546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2019, filed 13 Aug 2019.